Nasdaq Stockholm AB: 2cureX AB receives observation status (4/24)

Today, on January 4, 2024, 2cureX AB (the "Company") issued a press release
with information about changes to the Company's board of directors, resulting
in the board of directors not meeting applicable quorum requirements. 

The rules of Nasdaq First North Growth Market state that a listed company can
be given observation status if any circumstance exists that results in
substantial uncertainty regarding the issuer or the pricing of its financial
instruments. 

With reference to the above, Nasdaq Stockholm AB decides that the shares in
2cureX AB (2CUREX, ISIN code SE0010468124, order book ID 146225) shall be given
observation status. 

For further information about this exchange notice please contact Enforcement &
Investigations, telephone [phone].